← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Long Island Jewish Medical Center
New Hyde Park, NY
$31,736,050
Total funding
49
Grants
Funding mix
By agency
NIH$31,736,050 · 49
By mechanism
R01$17,426,183 · 21
P50$7,247,905 · 5
P30$3,679,461 · 7
K23$1,065,493 · 4
R10$547,824 · 1
R21$423,372 · 2
Investigators at Long Island Jewish Medical Center
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
COURSE OF ILLNESS IN SCHIZOPHRENIA: OPTIMIZING OUTCOMES$1,302,661
P30 · FY2002 · MH
PAPILLOMAS FROM THE UPPER RESPIRATORY TRACT$1,270,192
P50 · FY2002 · DC
COURSE OF ILLNESS IN SCHIZOPHRENIA: OPTIMIZING OUTCOMES$1,264,716
P30 · FY2001 · MH
PAPILLOMAS FROM THE UPPER RESPIRATORY TRACT$1,245,073
P50 · FY2001 · DC
COURSE OF ILLNESS IN SCHIZOPHRENIA: OPTIMIZING OUTCOMES$1,226,487
P30 · FY2000 · MH
PAPILLOMAS FROM THE UPPER RESPIRATORY TRACT$1,212,405
P50 · FY2000 · DC
PREVENTING MORBIDITY IN FIRST EPISODE SCHIZOPHRENIA$1,131,239
R01 · FY2001 · MH
PREVENTING MORBIDITY IN FIRST EPISODE SCHIZOPHRENIA$1,046,035
R01 · FY2000 · MH
PREVENTING MORBIDITY IN FIRST EPISODE SCHIZOPHRENIA$793,879
R01 · FY2002 · MH
TREATMENT AND OUTCOME OF EARLY ONSET BIPOLAR DISORDER$649,551
R01 · FY2002 · MH
TARGETING DISABILITIES FOR REHAB IN BIPOLAR DISORDER$645,432
R01 · FY2002 · MH
NEUROPSCYHOLOGY OF PSYCHIATRY DISABILITY &SERVICE NEED$625,070
R01 · FY2001 · MH
TREATMENT AND OUTCOME OF EARLY ONSET BIPOLAR DISORDER$556,358
R01 · FY2001 · MH
Treating Refractory Childhood Schizophrenia$499,367
R01 · FY2001 · MH
Treating Refractory Childhood Schizophrenia$493,659
R01 · FY2002 · MH
MULTICENTER TRIAL OF SYNSORB PK IN E COLI RELATED HUS$419,603
R01 · FY2000 · DK
TARGETING DISABILITIES FOR REHAB IN BIPOLAR DISORDER$413,238
R01 · FY2001 · MH
OPTIMIZATION OF PHOTODYNAMIC THERAPY USING MESO-TETRA(HYDROXYPHENYL) CLORIN$408,465
P50 · FY2000 · DC
REGULATION OF PAPILLOMAVIRUS EXPRESSION BY EPIDERMAL GROWTH FACTOR$408,465
P50 · FY2001 · DC
CELLULAR FACTORS DETERMINING THE VARIANT BEHAIVOR OF HPV 11$408,465
P50 · FY2000 · DC